Form 4: EyePoint Director Reports Stock Option Grant, RSU Vesting
Insider Transaction Report
EyePoint, Inc. Director Nancy Lurker reported the acquisition of 40,000 stock options and the vesting of 12,666 restricted stock units, converting to common stock.
Summary
- Nancy Lurker, a Director at EyePoint, Inc. (EYPT), reported changes in her beneficial ownership through a Form 4 filing.
- She acquired 40,000 stock options on January 2, 2026, with an exercise price of $17.48 per share. These options become exercisable on January 2, 2027, and expire on January 2, 2036.
- On January 5, 2026, 12,666 restricted stock units (RSUs) vested and converted into common stock. These RSUs were part of a grant that vests in three ratable annual installments beginning January 5, 2025.
- Following these transactions, Ms. Lurker's direct beneficial ownership of common stock is 219,213 shares.
- She also has indirect beneficial ownership of 126,889 shares of common stock held in a Family Trust, for which she disclaims beneficial ownership.
- Her beneficial ownership of derivative securities (stock options) is 40,000.
Sentiment
Score: 6
Explanation: The filing reports routine insider equity compensation events (stock option grant and RSU vesting), which are generally neutral to slightly positive as they align management incentives with shareholder interests. No significant positive or negative financial performance data is included.
Positives
- Director Nancy Lurker received a grant of 40,000 stock options, aligning her incentives with the company's long-term performance.
- The vesting of 12,666 restricted stock units into common stock increases the director's direct equity stake in EyePoint, Inc.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Indirect beneficial ownership of 126,889 common shares is held in a Family Trust for the benefit of the reporting person's children, with the spouse as trustee. The reporting person disclaims beneficial ownership of these securities.
Stakeholder Impact
- Shareholders: The equity compensation events (stock option grant and RSU vesting) for a director generally indicate continued alignment of management's interests with shareholder value creation.
Next Steps
- Future vesting installments for the remaining restricted stock units.
- Potential exercise of the newly granted stock options after January 2, 2027.
Key Dates
| Date | Description |
|---|---|
| 01/05/2025 | First ratable annual installment vesting date for restricted stock units. |
| 01/02/2026 | Date of stock option acquisition. |
| 01/05/2026 | Date of restricted stock unit vesting and conversion to common stock. |
| 01/06/2026 | Date the Form 4 was signed by Attorney-in-Fact. |
| 01/02/2027 | Date stock options become exercisable. |
| 01/02/2036 | Expiration date of stock options. |
Keywords
EyePoint Inc, EYPT, Nancy Lurker, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, Equity Compensation, Director Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.